Data / Form D filings / Mati Therapeutics Inc.
Mati Therapeutics Inc.: Form D filings
Mati Therapeutics Inc., a biotechnology company in Austin, TX, filed 7 Form D notices with the SEC between 2013 and 2026. The latest, on July 2, 2026, reports $2.6 million sold of a $4.9 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 Colorado Street Suite 2409, Austin, TX, 78701
- Phone
- (512) 720-1333
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1574251
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Amendment | $4,896,500 | $2,649,815 | $2,246,685 | 2 | Sep 12, 2025 | sec.gov |
| Oct 8, 2025 | New notice | $10,523,695 | $9,867,695 | $656,000 | 13 | Sep 30, 2025 | sec.gov |
| Sep 23, 2025 | New notice | $2,184,175 | $2,184,175 | 1 | Sep 12, 2025 | sec.gov | |
| May 24, 2019 | New notice | $1,500,000 | $165,030 | $1,334,970 | 2 | May 11, 2019 | sec.gov |
| Oct 16, 2018 | New notice | $1,200,000 | $50,000 | $1,150,000 | 1 | Oct 1, 2018 | sec.gov |
| Oct 10, 2014 | New notice | $13,800,000 | $150,000 | $13,650,000 | 2 | Sep 30, 2014 | sec.gov |
| Apr 15, 2013 | New notice | $10,000,000 | $1,310,000 | $8,690,000 | 13 | Apr 3, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Butchofsky | Executive Officer, Director | |
| Christopher Muller | Executive Officer, Director | |
| Joseph Tortorice III | Director | |
| Cameron Nelson | Executive Officer | |
| Peter McDonnell | Director | |
| Ken Jones | Director | |
| Jim Mazzo | Director | |
| Dave Fellows | Director | |
| Linda Lupini | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jun 29, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mati Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.